July 08, 2013
2 min read
Save

Stress Cardiac MRI Effective in Known, Suspected Stable CAD

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

The use of stress cardiac MRI in patients with known or suspected stable CAD effectively reclassified risk for cardiac death and non-fatal MI beyond clinical covariates, according to study results.

Perspective from William E. Boden, MD

“Cardiac MRI improved risk reclassification in the majority of patients at intermediate-to-high pre-test risk, regardless of status of prior CAD, across American College of Cardiology/American Heart Association practice guideline recommended strata that guide current clinical management decisions,” the researchers wrote.

The study, which was published recently in Circulation, included a cohort of consecutive patients referred for evaluation of myocardial ischemia. Researchers determined net reclassification improvement (NRI) of the primary outcome of MACE, a composite of cardiac death and nonfatal MI; this was incremental to clinical risk models, using guideline-based low (<1%), moderate (1%-3%) and high (>3%) annual risk categories.

Researchers reported that inducible ischemia had a significant association with MACE (HR=14.66; P<.0001), and low event rates of MACE (0.6%) and cardiac death (0.4%). This prognostic utility was observed in patients with prior CAD (HR=8.17; P<.0001).

The addition of inducible ischemia to the multivariable clinical risk model enhanced discrimination of MACE (C-statistic 0.81-0.86, P=.04; adjusted HR=7.37, P<.0001). The addition also reclassified 91.5% of patients at moderate pre-test risk (65.7% moderate-to-low risk; 25.8% to high risk) with corresponding changes in the observed event rates of 0.3% per year for low-risk post-test and 4.9% per year for high-risk post-test.

Additional data indicated a categorical NRI of 0.229 (95% CI 0.063-0.391) and a continuous NRI of 1.11 (95% CI 0.81-1.39).

Disclosure: Shah reports no relevant financial disclosures.